The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
The miR-106b-25 cluster targets Smad7, activates TGF-β signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer
Open accessAbstract
The role of TGF-β signaling in tumorigenesis is paradoxical: it can be tumor suppressive or tumor promotional, depending on context. The metastatic regulator, Six1, was recently shown to mediate this switch, providing a novel means to explain this elusive ‘TGF-β paradox’. Herein, we identify a mechanism by which Six1 activates the tumor promotional arm of TGF-β signaling, via its ability to upregulate the miR-106b-25 microRNA cluster, and further identify a novel function for this cluster of microRNAs. Although expression of the miR-106b-25 cluster is known to overcome TGF-β-mediated growth suppression via targeting p21 and BIM, we demonstrate for the first time that this same cluster can additionally target the inhibitory Smad7 protein, resulting in increased levels of the TGF-β type I receptor and downstream activation of TGF-β signaling. We further show that the miR-106b-25 cluster is sufficient to induce an epithelial-to-mesenchymal transition and a tumor initiating cell phenotype, and that it is required downstream of Six1 to induce these phenotypes. Finally, we demonstrate a significant correlation between miR-106b, Six1, and activated TGF-β signaling in human breast cancers, and further show that high levels of miR-106b and miR-93 in breast tumors significantly predicts shortened time to relapse. These findings expand the spectrum of oncogenic functions of miR-106b-25, and may provide a novel molecular explanation, through the Six1 regulated miR-106b-25 cluster, by which TGF-β signaling shifts from tumor suppressive to tumor promoting.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,672
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
van de Vijver, M. J., He, Y. D., van 't Veer, L. J., Dai, H., Hart, A. A. M., Voskuil, D. W., Schreiber, G. J., Peterse, J. L., Roberts, C., Marton, M. J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021967 · Cited by 6,488
Massagué, J. (2008) · Cell · doi:10.1016/j.cell.2008.07.001 · Cited by 3,907
A microRNA polycistron as a potential human oncogene
He, L., Thomson, J. M., Hemann, M. T., Hernando-Monge, E., Mu, D., Goodson, S., Powers, S., Cordon-Cardo, C., Lowe, S. W., Hannon, G. J., et al. (2005) · Nature · doi:10.1038/nature03552 · Cited by 3,483
Epithelial-Mesenchymal Transition in Breast Cancer Relates to the Basal-like Phenotype
Sarrió, D., Rodriguez-Pinilla, S. M., Hardisson, D., Cano, A., Moreno-Bueno, G., & Palacios, J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2017 · Cited by 1,056
TGFβ Primes Breast Tumors for Lung Metastasis Seeding through Angiopoietin-like 4
Padua, D., Zhang, X. H.-F., Wang, Q., Nadal, C., Gerald, W. L., Gomis, R. R., & Massagué, J. (2008) · Cell · doi:10.1016/j.cell.2008.01.046 · Cited by 952
E2F1-Regulated MicroRNAs Impair TGFβ-Dependent Cell-Cycle Arrest and Apoptosis in Gastric Cancer
Petrocca, F., Visone, R., Onelli, M. R., Shah, M. H., Nicoloso, M. S., de Martino, I., Iliopoulos, D., Pilozzi, E., Liu, C.-G., Negrini, M., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.02.013 · Cited by 831
Module Map of Stem Cell Genes Guides Creation of Epithelial Cancer Stem Cells
Wong, D. J., Liu, H., Ridky, T. W., Cassarino, D., Segal, E., & Chang, H. Y. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.02.009 · Cited by 720
Regulation of TGF-β signaling by Smad7
Yan, X., Liu, Z., & Chen, Y. (2009) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmp018 · Cited by 436
Poliseno, L., Salmena, L., Riccardi, L., Fornari, A., Song, M. S., Hobbs, R. M., Sportoletti, P., Varmeh, S., Egia, A., Fedele, G., et al. (2010) · Science Signaling · doi:10.1126/scisignal.2000594 · Cited by 410
Implications of the Cancer Stem-Cell Hypothesis for Breast Cancer Prevention and Therapy
Kakarala, M., & Wicha, M. S. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.3931 · Cited by 403
Buffa, F. M., Camps, C., Winchester, L., Snell, C. E., Gee, H. E., Sheldon, H., Taylor, M., Harris, A. L., & Ragoussis, J. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0489 · Cited by 308
MicroRNA miR-93 promotes tumor growth and angiogenesis by targeting integrin-β8
Fang, L., Deng, Z., Shatseva, T., Yang, J., Peng, C., Du, W. W., Yee, A. J., Ang, L. C., He, C., Shan, S. W., et al. (2011) · Oncogene · doi:10.1038/onc.2010.465 · Cited by 307
Small RNA-mediated regulation of iPS cell generation: RNA-based iPSC reprogramming
Li, Z., Yang, C.-S., Nakashima, K., & Rana, T. M. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.2 · Cited by 302
Kan, T., Sato, F., Ito, T., Matsumura, N., David, S., Cheng, Y., Agarwal, R., Paun, B. C., Jin, Z., Olaru, A. V., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.02.002 · Cited by 266
Role of the miR‐106b‐25 microRNA cluster in hepatocellular carcinoma
Li, Y., Tan, W., Neo, T. W. L., Aung, M. O., Wasser, S., Lim, S. G., & Tan, T. M. C. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01164.x · Cited by 255
Micalizzi, D. S., Christensen, K. L., Jedlicka, P., Coletta, R. D., Barón, A. E., Harrell, J. C., Horwitz, K. B., Billheimer, D., Heichman, K. A., Welm, A. L., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37815 · Cited by 232
Self-citationSmad7: not only a regulator, but also a cross-talk mediator of TGF-β signalling
Yan, X., & Chen, Y.-G. (2011) · Biochemical Journal · doi:10.1042/bj20101827 · Cited by 208
Brett, J. O., Renault, V. M., Rafalski, V. A., Webb, A. E., & Brunet, A. (2011) · Aging · doi:10.18632/aging.100285 · Cited by 207
Switching TGFβ from a tumor suppressor to a tumor promoter
Inman, G. J. (2011) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.12.004 · Cited by 197
The TGF-β Paradox in Human Cancer: An Update
Tian, M., & Schiemann, W. P. (2009) · Future Oncology · doi:10.2217/14796694.5.2.259 · Cited by 196
Jørgensen, S., Baker, A., Møller, S., & Nielsen, B. S. (2010) · Methods · doi:10.1016/j.ymeth.2010.07.002 · Cited by 189
McCoy, E. L., Iwanaga, R., Jedlicka, P., Abbey, N.-S., Chodosh, L. A., Heichman, K. A., Welm, A. L., & Ford, H. L. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37691 · Cited by 172
Self-citationMicroRNAs as therapeutic targets in cancer
Nana-Sinkam, S. P., & Croce, C. M. (2011) · Translational Research · doi:10.1016/j.trsl.2011.01.013 · Cited by 168
Ford, H. L., Kabingu, E. N., Bump, E. A., Mutter, G. L., & Pardee, A. B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.21.12608 · Cited by 165
Self-citationShtutman, M. S., Levina, E. M., Ohouo, P. Y., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2106 · Cited by 135
Micalizzi, D. S., Wang, C.-A., Farabaugh, S. M., Schiemann, W. P., & Ford, H. L. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1354 · Cited by 111
Self-citationThe Pro-Apoptotic Protein Bim Is a MicroRNA Target in Kidney Progenitors
Ho, J., Pandey, P., Schatton, T., Sims‐Lucas, S., Khalid, M., Frank, M. H., Hartwig, S., & Kreidberg, J. A. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010080841 · Cited by 101
Coletta, R. D., Christensen, K. L., Micalizzi, D. S., Jedlicka, P., Varella‐Garcia, M., & Ford, H. L. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-3141 · Cited by 96
Self-citationMicroRNA expression profile of bronchioalveolar stem cells from mouse lung
Qian, S., Ding, J., Xie, R., An, J., Xu-jun, A., Zhao, Z.-G., Sun, J., Duan, Y., Chen, Z., & Zhu, B. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.10.052 · Cited by 74
HOXA9 regulates miR-155 in hematopoietic cells
Hu, Y., Fong, S., Largman, C., & Shen, W.-F. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq337 · Cited by 43
“Mir”acles in hox gene regulation
Chopra, V. S., & Mishra, R. K. (2006) · BioEssays · doi:10.1002/bies.20401 · Cited by 39
E2F1-Regulated MicroRNAs Impair TGFb-Dependent Cell-Cycle Arrest and Apoptosis in Gastric Cancer
Petrocca, F., Visone, R., Onelli, M. R., Shah, M. H., Nicoloso, M. S., Martino, I. D., Iliopoulos, D., Pilozzi, E., Liu, C., Negrini, M., et al. (2008) · Cited by 30
Cited by
Molecular mechanisms of epithelial–mesenchymal transition
Lamouille, S., Xu, J., & Derynck, R. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3758 · Cited by 8,091
Mogilyansky, E., & Rigoutsos, I. (2013) · Cell Death & Differentiation · doi:10.1038/cdd.2013.125 · Cited by 889
Regulation of TGF-β Family Signaling by Inhibitory Smads
Miyazawa, K., & Miyazono, K. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022095 · Cited by 439
Breast cancer diagnosis: Imaging techniques and biochemical markers
Jafari, S. H., Saadatpour, Z., Salmaninejad, A., Momeni, F., Mokhtari, M., Nahand, J. S., Rahmati, M., Mirzaei, H., & Kianmehr, M. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26379 · Cited by 410
Parikh, A., Lee, C., Joseph, P., Marchini, S., Baccarini, A., Kolev, V., Romualdi, C., Fruscio, R., Shah, H., Wang, F., et al. (2014) · Nature Communications · doi:10.1038/ncomms3977 · Cited by 258
Metadata
- Authors
- Smith, A. L., Iwanaga, R., Drasin, D. J., Micalizzi, D. S., Vartuli, R. L., Tan, A.-C., & Ford, H. L.
- Venue
- Oncogene
- Published
- 2012-01-30
- Volume
- 31
- Issue
- 50
- Pages
- 5162-5171
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2137751769
- Cited by
- 293
- References
- 34
- FWCI
- 11.50
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.